Show items per page
Elements: 113
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure Marcelin, Anne-Geneviève; Delaugerre, Constance; Beaudoux, Céline; Descamps, Diane; ... Flandre, Philippe 2013
add to browser selection
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART Fagard, Catherine; Le Braz, Michelle; Gunthard, Huldrych; Hirsch, H. H.; ... Hirschel, Bernard 2003
add to browser selection
A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study Yerly Ferrillo, Sabine; Perneger, T. V.; Hirschel, Bernard; Dubuis, O.; ... Perrin, Luc 1998
add to browser selection
A patient with HIV-1 superinfection Jost, Stéphanie; Bernard, Marie-Charlotte; Kaiser, Laurent; Yerly Ferrillo, Sabine; ... Perrin, Luc 2002
add to browser selection
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients Ananworanich, Jintanat; Hill, Andrew; Siangphoe, Umaporn; Ruxrungtham, Kiat; ... Hirschel, Bernard 2005
add to browser selection
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection Fagard, Catherine; Oxenius, Annette; Gunthard, Huldrych; Garcia, Felipe; ... Hirschel, Bernard 2003
add to browser selection
A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection Cardiello, Peter; Hassink, Elly; Ananworanich, Jintanat; Srasuebkul, Preeyaporn; ... Cooper, David 2005
add to browser selection
A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study Pichard, Claude; Sudre, Philippe; Karsegard, V.; Yerly Ferrillo, Sabine; ... Hirschel, Bernard 1998
add to browser selection
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy Hirsch, M.; Steigbigel, R.; Staszewski, S.; Mellors, J.; ... Leavitt, R. 1999
add to browser selection
Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis Ford, Nathan; Calmy, Alexandra; Andrieux-Meyer, Isabelle; Hargreaves, Sally; ... Shubber, Zara 2013
add to browser selection
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Erard, V.; Weber, R.; ... Telenti, A. 1999
add to browser selection
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration Lewden, Charlotte; Bouteloup, Vincent; De Wit, Stéphane; Sabin, Caroline; ... Chêne, Geneviève 2012
add to browser selection
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study Wunder, D M.; Fux, C A.; Bersinger, N A.; Mueller, N J.; ... Furrer, H. 2008
add to browser selection
Antiretroviral treatment during pregnancy Keiser, Olivia; Gayet-Ageron, Angèle; Rudin, Christoph; Brinkhof, M. W.; ... de Tejada, B. M. 2008
add to browser selection
Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study Vanhems, P.; Lambert, J.; Guerra, M.; Hirschel, Bernard; Allard, Robert 1999
add to browser selection
Beware of drug holidays before HIV salvage therapy Hirschel, Bernard 2003
add to browser selection
Biphasic decline of CD4 cell count during scheduled treatment interruptions Fagard, Catherine; Bandelier, C. Y.; Ananworanich, Jintanat; Le Braz, Michelle; ... Hirschel, Bernard 2005
add to browser selection
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP) Ciaffi, Laura; Koulla-Shiro, Sinata; Sawadogo, Adrien Bruno; Ndour, Cheik Tidiane; ... Calmy, Alexandra 2017
add to browser selection
Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS Vanhems, Philippe; Voirin, Nicolas; Hirschel, Bernard; Cooper, David; ... Perrin, Luc 2003
add to browser selection
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study Wittkop, Linda; Arsandaux, Julie; Trevino, Ana; Schim van der Loeff, Maarten; ... Matheron, Sophie 2017
add to browser selection
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study Kaufmann, G. R.; Perrin, Luc; Pantaleo, Guiseppe; Opravil, Milos; ... Battegay, Manuel 2003
add to browser selection
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy Khanna, Nina; Opravil, Milos; Furrer, Hansjakob; Cavassini, Matthias; ... Kaufmann, Gilbert R. 2008
add to browser selection
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy Wolbers, Marcel; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; ... Bucher, H. C. 2007
add to browser selection
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2 Asmuth, David M.; Goodrich, James; Cooper, David A.; Haubrich, Richard; ... Valdez, Hernan 2010
add to browser selection
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial Ananworanich, Jintanat; Gayet-Ageron, Angèle; Le Braz, Michelle; Prasithsirikul, Wisit; ... Hirschel, Bernard 2006
add to browser selection
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy Rohrbach, Janine; Robinson, Nicola; Harcourt, Gillian; Hammond, Emma; ... Rauch, Andri 2010
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
Chemotherapy for AIDS-related malignancies does not increase HIV viraemia Rutschmann, Olivier Thierry; Pechere, Marc; Krischer, J.; Perrin, Luc; Hirschel, Bernard 1997
add to browser selection
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer 2002
add to browser selection
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Greub, Gilbert; Ledergerber, Bruno; Battegay, M.; Grob, P.; ... Telenti, A. 2000
add to browser selection
Colour vision in AIDS patients without HIV retinopathy Sommerhalder, Jorg; Baglivo, Edoardo; Barbey, Catherine; Hirschel, Bernard; ... Pelizzone, Marco 1998
add to browser selection
Combined therapy with zidovudine and L-697,661 in primary HIV infection Perrin, Luc; Rakik, A.; Yerly Ferrillo, Sabine; Baumberger, Christophe; ... Hirschel, Bernard 1996
add to browser selection
Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney Vanhems, P.; Hughes, J.; Collier, A. C.; Vizzard, J.; ... Hirschel, Bernard 2000
add to browser selection
Controversies: does the CD4+ cell count reflect clinical efficacy? Kinloch-de-Loes, S.; Perrin, L. H.; Hirschel, Bernard; Perneger, T. V. 1996
add to browser selection
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study Group Stalder, N.; Sudre, Philippe; Olmari, M.; Opravil, M.; ... Hirschel, Bernard 1997
add to browser selection
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland Crisinel, Pierre-Alex; Posfay Barbe, Clara; Aebi, Christoph; Cheseaux, Jean-Jacques; ... Siegrist, Claire-Anne 2012
add to browser selection
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland Myers, Catherine; Posfay Barbe, Clara; Aebi, Christoph; Cheseaux, Jean-Jacques; ... Siegrist, Claire-Anne 2009
add to browser selection
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals Elzi, Luigia; Kaufmann, Gilbert; Weber, Rainer; Fux, C. A.; ... Battegay, Manuel 2009
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Disentangling human tolerance and resistance against HIV. Regoes, Roland R; McLaren, Paul J; Battegay, Manuel; Bernasconi, Enos; ... Fellay, Jacques 2014
add to browser selection
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir Karrer, Urs; Ledergerber, Bruno; Furrer, Hansjakob; Elzi, Luigia; ... Speck, R. F. 2005
add to browser selection
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine Yerly Ferrillo, Sabine; Kaiser, Laurent; Baumberger, C.; Hirschel, Bernard; Perrin, Luc 1995
add to browser selection
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study Young, J; Scherrer, Anne Paule Marie; Günthard, H F; Opravil, M; ... Bucher, H C 2011
add to browser selection
Ferritin levels during structured treatment interruption of highly active antiretroviral therapy Boom, J.; Kosters, E.; Duncombe, C.; Kerr, S.; ... Ananworanich, J. 2007
add to browser selection
Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load Oxenius, Annetie; Sewell, A. K.; Dawson, S. J.; Gunthard, Huldrych; ... Price, D. A. 2002
add to browser selection
High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study Schäfer, Juliane; Young, Jim; Calmy, Alexandra; Nicca, Dunja; ... Bucher, Heiner C 2017
add to browser selection
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study Ananworanich, Jintanat; Siangphoe, Umaporn; Hill, Andrew; Cardiello, Peter; ... Ruxrungtham, Kiat 2005
add to browser selection
HIV transmission under highly active antiretroviral therapy Vernazza, Pietro; Hirschel, Bernard; Bernasconi, Enos; Flepp, Markus 2008
<< previous | 1 | 2 | 3 |